ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt

ClinicalTrials.gov ID: NCT00442364

Public ClinicalTrials.gov record NCT00442364. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 8:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label Multicenter Safety Study of the Varisolve® Procedure for the Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt

Study identification

NCT ID
NCT00442364
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Boston Scientific Corporation
Industry
Enrollment
60 participants

Conditions and interventions

Conditions

Interventions

  • Endovenous Microfoam Occlusion Procedure
  • Polidocanol (1%) Microfoam (Varisolve) Drug

Procedure · Drug

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2007
Primary completion
May 31, 2008
Completion
Jul 31, 2009
Last update posted
Apr 20, 2021

2007 – 2009

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
Not listed Los Angeles California 90033
Not listed Durham North Carolina 27710
Not listed Winston-Salem North Carolina 27157
Not listed Philadelphia Pennsylvania 19107
Not listed Pittsburgh Pennsylvania 15232
Not listed Houston Texas 77030
Not listed Bellevue Washington 98004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00442364, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2021 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00442364 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →